Nasal-spraying LiveSpo NAVAX: Probiotics of the next generation for respiratory infections
HANOI, VIETNAM - Media OutReach - 15 August 2022 -On July 20nd, the Scientific Reports journal (the Nature) officially annouced a break-through research on using LiveSpo NAVAX probiotic spores in nasal spray form to support the treatment of acute respiratory infections in children infected with respiratory syncytial virus (RSV) [1]
Respiratory syncytial virus (RSV) is a leading cause of Acute Respiratory Tract Infections (ARTIs) in young children.
The World Health Organization estimates that 48,000-74,000 children - younger than five years old die yearly due to RSV infection. Up to now, there is no available vaccine and specific treatment for RSV-infected children.
Researchers at Vietnam National Children’s Hospital conducted the first clinical trial in infected children with Respiratory Syncytial Virus (RSV). They demonstrated the safety and beneficial effects of a nasal-spraying liquid suspension of Bacillus spore probiotics (LiveSpo® NAVAX) in the supportive treatment of ARTIs.
The research team published results showing that the nasal-spraying LiveSpo NAVAX) reduced the load of RSV and influenza virus by 300-fold and 1000-fold, and was 50- to 70-fold more effective than physiological saline after 2-3 days of treatment.
Semi-quantitative real-time PCR results of co-infection bacteria on day three of treatment show that patients in the NAVAX) group (spraying probiotics spores) were negative while patients in the control group (not using probiotic spores) only had a slight decrease in bacterial co-infection concentration.
The team also assessed that the nasal-spraying Bacillus spores could rapidly and effectively relieve symptoms of RSV-induced ARTIs while exhibiting a strong effect in reducing viral load and inflammation.
Nasal-spraying probiotics may provide the basis for simple, low-cost, and effective symptomatic adjuvant treatment against viral infections.
Dr. Nguyen Hoa Anh - Director of Sporebiotics Research Center said: “The interaction mechanism between LiveSpo NAVAX) 's Bacillus spores and the virus and the nasal mucosal immune system is based on nonspecific binding suggesting that LiveSpo Navax may be helpful against viral variants that cause respiratory diseases or other rapidly emerging respiratory viruses such as influenza virus or coronavirus.
The research is a breakthrough scientific achievement, contributing to enhancing the image of Vietnam in the field of science in the international arena and making a great contribution to public health care, especially for children.
[1] Scientific Report (July 20th, 2022). “Nasal‑spraying Bacillus spores as an efective symptomatic treatment for children with acute respiratory syncytial virus infection” https://www.nature.com/articles/s41598-022-16136-z.pdf
Hashtag: #LiveSpo
About LiveSpo
LiveSpo® NAVAX containing more than 5-billion spores of beneficial bacteria Bacillus subtilis and Bacillus clausii, and 0.9% physiological saline up to 5mL.
The product supports to help clean ears, nose, throat; and prevent, reduce the risk of ear, nose, throat infections, and increase beneficial bacteria, protect and the nasal mucosa.
LOS ANGELES, USA - Newsaktuell - 31 January 2025 - High levels of governance have masked a slow decline in Germany, with political, economic, and social fractures "festering over years", a new scie...
SYDNEY, AUSTRALIA - Media OutReach Newswire - 3 February 2025 - VEGA, a global leader in AV/IT solutions, announces two major milestones: the relocation of its global headquarters to Champion Towe...
• Yunlin OWF fully operational and running at design capacity of 640 MW • Enough clean energy to power over 600,000 Taiwanese homes annually • Major s...
DUBAI, UAE - Media OutReach Newswire - 28 January 2025 - AstraZeneca, a leading multinational pharmaceutical and biotechnology company, has been recognized as the second-best place to work across...
RAMMELBURG, GERMANY - Newsaktuell - 3 February 2025 - Peter Karl Jugl refers to the Bild article from January 30, titled "This Could Be Elon Musk's New European Headquarters". Jugl, Managing Direct...
SINGAPORE - Media OutReach Newswire - 4 February 2025 - VAIO Corporation (Headquarters: Azumino City, Nagano Prefecture, President & CEO: Masaki Yamano, hereinafter referred to as "VAIO...
KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 4 February 2025 – Monash University Malaysia marked a milestone with the launch of the Southeast Asia Research Centre for Digital Tech and Societ...
SINGAPORE - Media OutReach Newswire - 4 February 2025 - IQ Dynamics, a leading enterprise software provider, is proud to offer HRiQ, an advanced HR management software designed to revolutionise ...
Preparations underway for a landmark 2025 including initiatives throughout the year with clients, alumni, the business community, and society
HONG KONG SAR - Media OutReach Newswire - 4 February 2...
Tickets to immersive cultural attraction set to honor football icon’s inspiring career go on sale from 5th February
HONG KONG SAR - Media OutReach Newswire - 4 February 2025 - The highly anticipat...
